Surgical Considerations for the Explantation of the Parachute Left Ventricular Partitioning Device and the Implantation of the Heartmate Ii Left Ventricular Assist Device

Abstract

Chronic heart failure is the leading cause of death in the world. With newer therapies, the burden of this disease has decreased; however, a significant number of patients remain refractive to existing therapies. Myocardial infarction often leads to ventricular remodeling and eventually contributes to heart failure. The Parachute^™ (Cardiokinetix, Menlo Park, CA) is the first device designed for percutaneous ventricular restoration therapy, which reduces left ventricular volume and minimizes the risk of open surgical procedures. For the first time, we report a case of explantation of the Parachute ventricular partitioning device and transition to a HeartMate II^™ left ventricular assist device and the surgical considerations for a successful outcome.